Abstract

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet

Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara

Issue: Jan/Feb 2010 - Pediatrics and Wellness

Page(s): 21-25

Download in electronic PDF format for $75
  • Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 1
  • Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 2
  • Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 3
  • Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 4
  • Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Page 5

Abstract

The ketogenic diet is a high-fat, lowcarbohydrate, and low-protein diet designed to increase the body’s dependence on fatty acids for energy rather than glucose. This diet is used as a treatment option for young children with refractory seizure disorders or inborn metabolic defects. Children on this diet must be closely monitored by a team of healthcare professionals consisting of neurologists, nurses, dieticians, and pharmacists. Accurate calculations for daily allowances of carbohydrates, fats, and proteins are essential for success of the treatment. Since pediatric patients that are on the ketogenic diet often take compounded medications, there is also a need to determine the carbohydrate content of the compounded medications. Researching and trying to calculate the carbohydrate content of compounded medications can be very time consuming. A group of PharmD candidates from Purdue University were provided with copies of the top 100 compounded oral liquids prepared at Clarian Health Partners, Inc. Their exte

Related Keywords

  • Lara Imai
  • children
  • seizure disorders
  • ketogenic diet
  • carbohydrates
  • metabolic disorders
  • glucose metabolism
  • excipients
  • oral liquid vehicles

Related Categories

  • EXCIPIENTS
  • NUTRITION AND NUTRICEUTICALS
  • PEDIATRICS
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2010
Pg. 21-25
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Mar/Apr 2007
Pg. 116-120
Challenges of Compounding for Patients on the Ketogenic Diet
Author(s): McElhiney Linda F
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2001
Pg. 65-67
Oral Liquid Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Nov/Dec 2018
Pg. 480-489
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Author(s): Cutaia Kara, Chablani Lipika, Zhao Fang
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Jul/Aug 2005
Pg. 275-278
Compounding for Endocrine Disorders in Adult Patients
Author(s): Grajeda Betty Jo, Vail Jane
Nov/Dec 2005
Pg. 456-461
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Author(s): Fonseca Simonne C
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
Nov/Dec 2022
Pg. 468-472
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2001
Pg. 21-22
Methylphenidate in the Treatment of Attention Deficit Disorders
Author(s): Tenreiro Kim
Sep/Oct 1999
Pg. 366-367
Feline Urologic Syndrome and Diet Formulation
Author(s): Long Scott F